Overview of Histone Deacetylase Inhibitors in Haematological Malignancies

Histone deacetylase inhibitors (HDACi) can induce hyperacetylation of both histone and non-histone target resulting in epigenetic reprogramming and altered activity, stability and localisation of non-histone proteins to ultimately mediate diverse biological effects on cancer cells and their microenv...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishton, Mark J., Johnstone, Ricky W., Dickinson, Michael, Harrison, Simon, Prince, H. Miles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033944/
https://www.ncbi.nlm.nih.gov/pubmed/27713371
http://dx.doi.org/10.3390/ph3082674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033944/
https://www.ncbi.nlm.nih.gov/pubmed/27713371
http://dx.doi.org/10.3390/ph3082674

Ejemplares similares